葵花药业：复方聚乙二醇(3350)电解质口服溶液获药品注册证

Group 1 - The core point of the article is that Kew Flower Pharmaceutical (002737.SZ) has received a drug registration certificate from the National Medical Products Administration for its compound polyethylene glycol (3350) electrolyte oral solution, which is indicated for the treatment of chronic constipation and fecal impaction [1] Group 2 - The approved drug is aimed at addressing specific gastrointestinal conditions, highlighting the company's focus on expanding its product offerings in the pharmaceutical market [1]